Connect with us

Health

CREB1: A Potential Target for Treating Pancreatic Cancer – Technology Networks

Preclinical research using cell lines, genetic mouse models and human pancreatic tumor tissue samples has identified the transcription factor CREB1 as a potential…

Published

on

Article feature image

Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor CREB1 (for cyclic AMP-responsive element binding protein 1) as a potential therapeutic target for the treatment of pancreatic cancer, according to results presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15. This study is being simultaneously published in Cancer Discovery, a journal of the American Association for Cancer Research.
Pancreatic…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Inexpensive test for rapid detection of COVID-19 with 90% accuracy – News-Medical.Net
Article feature image
Research provides new insight into anesthesia-associated tau spreading in the brain – News-Medical.Net